TL;DR
This study investigates unilateral high myopia (uHM), a condition where one eye is significantly more myopic than the other, often leading to severe vision loss. By combining detailed clinical examinations with exome sequencing in 75 families, researchers identified genetic defects in nearly 27% of uHM cases, revealing that significant retinal complications can be hidden beneath a seemingly normal myopic fundus. This highlights the critical need for comprehensive peripheral retinal screening and genetic testing in uHM patients to prevent vision-threatening outcomes.
What Problem Does This Paper Address?
Unilateral high myopia (uHM) is a challenging condition, particularly in its "simplex" form, where it appears without other obvious ocular or systemic diseases. While often diagnosed in childhood, uHM can lead to severe consequences like amblyopia (lazy eye), strabismus (crossed eyes), and retinal detachment, often with a poor prognosis. The challenge lies in the fact that the "good" eye can compensate, masking the severity of the problem, and that routine examinations might miss subtle but critical peripheral retinal changes. Existing research has focused more on bilateral high myopia, leaving a gap in understanding the genetic and clinical landscape of uHM, especially in identifying hidden risks. This paper aims to fill that gap by systematically analyzing a cohort of uHM patients to uncover both clinical and genetic factors contributing to severe outcomes.
Methods
The researchers employed a multi-pronged approach:
- Clinical Examination: All 75 probands underwent thorough ophthalmological examinations. This included standard tests like fundus photography, but crucially, also extended to ultra-wide-field imaging, optical coherence tomography (OCT), and fundus fluorescein angiography (FFA). This comprehensive approach was designed to detect subtle peripheral retinal changes that might be missed in routine checks.
- Exome Sequencing: Genomic DNA from the probands was analyzed using whole-exome sequencing (WES) or targeted exome sequencing (TES) of a panel of 736 eye-related genes. This allowed for the identification of genetic variants.
- Bioinformatic and Co-segregation Analysis: Detected genetic variants were filtered using multiple bioinformatic tools and databases (e.g., SIFT, Polyphen-2, gnomAD, HGMD). Variants were then evaluated based on ACMG/AMP criteria for pathogenicity. Crucially, co-segregation analysis was performed within families to confirm that identified variants were indeed linked to the condition.
- Genotype-Phenotype Correlation: The identified genetic variants were correlated with the observed clinical phenotypes, particularly the peripheral retinal changes, to understand how specific genes relate to specific ocular manifestations.
Datasets
The study utilized a dataset of 75 unrelated probands with simplex unilateral high myopia recruited from the Zhongshan Ophthalmic Center. This cohort was supplemented with publicly available genetic databases such as gnomAD and HGMD for variant filtering and evaluation. No new benchmark datasets were introduced.
Key Insights and Ideas
- Hidden Dangers: The most striking insight is that nearly half (48%) of patients initially diagnosed with simplex uHM showed significant peripheral retinal changes upon extensive examination, even when their posterior pole appeared normal. This underscores that uHM is not just about refractive error but can harbor underlying conditions that threaten vision.
- Genetic Link is Strong: The study found that a substantial proportion (26.7%) of uHM cases had identifiable genetic defects in genes known to be associated with ocular diseases. This is comparable to the genetic findings in early-onset bilateral high myopia, suggesting a similar genetic etiology.
- Specific Gene-Phenotype Links: Different gene categories were associated with distinct peripheral retinal changes. For instance, genes linked to Stickler syndrome were more often associated with pigmentary changes and lattice degeneration, while genes related to Familial Exudative Vitreoretinopathy (FEVR) were linked to avascular zones and neovascularization.
- Importance of Peripheral Screening: The findings strongly advocate for a thorough examination of the entire peripheral retina, not just the posterior pole, in all uHM patients, including the less myopic eye. This is crucial for early detection of risk factors for serious complications.
- Genetic Counseling is Key: The identification of genetic causes provides a powerful tool for genetic counseling, offering insights for family members and potentially identifying carriers of X-linked conditions.
Key Results
- Genetic Variants: 21 potential pathogenic variants in 13 genes were identified in 20 out of 75 (26.7%) probands.
- Peripheral Retinal Changes: 48% of probands exhibited peripheral retinal changes, including avascular zones (74.6%), neovascularization (54.0%), and fluorescein leakage (31.7%).
- Gene Associations: Variants in Stickler syndrome-related genes (COL11A1, COL2A1) and FEVR-related genes (FZD4, LRP5, TSPAN12) were the most common identified genetic causes.
- Myopic Maculopathy: The 20 probands with genetic defects showed a trend towards more severe myopic maculopathy compared to those without identified genetic variants.
- Visual Acuity Improvement: Following intervention (optical correction and patching), a significant improvement in best-corrected visual acuity (BCVA) was observed in the highly myopic eyes of uHM probands.
Limitations and Future Work
The authors acknowledge several limitations:
- Follow-up Duration: The variable follow-up duration and a limited number of participants in the follow-up study restrict definitive conclusions about treatment outcomes.
- Compliance and Controls: Lack of placebo controls and variability in patient compliance with interventions make it challenging to precisely assess treatment effectiveness.
- Early Childhood Manifestations: Some extra-ocular manifestations of genetic syndromes associated with uHM may not be obvious in early childhood, requiring long-term observation.
- Comprehensive Testing: Not all valuable examinations (like SLO, FFA) could be performed on all probands due to their young age.
Future work should focus on prospective cohort studies with longer follow-up periods to accurately assess the effectiveness of clinical interventions. Further research is also needed to understand the exact molecular mechanisms by which genetic defects lead to asymmetric ocular growth and to explore the potential benefits of interventions like low-concentration atropine and orthokeratology for uHM. The study also suggests that genetic screening for uHM patients is crucial for early detection and informed genetic counseling.
Summary updated